Table 3 Relationship of covariates to blood glucose and HbA1c measurements

0.2268

0.8062

107.80 ± 1.34

(105.15, 110.44)

5.51 ± 0.10

(5.31, 5.71)

109.70 ± 1.07

(107.58, 111.81)

5.48 ± 0.07

(5.33, 5.64)

0.075

0.3041

105.09 ± 2.10

(100.96, 109.22)

5.33 ± 0.15

(5.01, 5.64)

108.83 ± 1.75

(105.38, 112.27)

5.44 ± 0.13

(5.17, 5.71)

109.69 ± 1.43

(106.88, 112.51)

5.62 ± 0.10

(5.42, 5.83)

111.37 ± 1.32

(108.77, 113.97)

5.61 ± 0.09

(5.42, 5.79)

0.4579

0.6887

   candesartan cilexetil

110.93 ± 1.31

(108.34, 113.51)

5.62 ± 0.10

(5.41, 5.82)

   losartan potassium

107.73 ± 2.01

(103.77, 111.69)

5.52 ± 0.12

(5.28, 5.77)

   olmesartan medoxomil

106.99 ± 2.24

(102.58, 111.40)

5.37 ± 0.15

(5.06, 5.68)

   telmisartan

108.57 ± 2.16

(104.31, 112.83)

5.43 ± 0.16

(5.10, 5.76)

   valsartan

109.51 ± 1.56

(106.44, 112.59)

5.55 ± 0.12

(5.30, 5.81)

<.0001

0.6014

111.98 ± 1.16

(109.70, 114.27)

reference*

5.51 ± 0.07

(5.37, 5.66)

reference*

105.86 ± 1.13

(103.64, 108.09)

<.0001*

5.50 ± 0.07

(5.35, 5.65)

0.8209*

107.78 ± 1.48

(104.87, 110.69)

0.0081*

5.44 ± 0.08

(5.28, 5.61)

0.2582*

109.36 ± 1.63

(106.16, 112.56)

0.1308*

5.54 ± 0.08

(5.37, 5.70)

0.7457*